arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Target Group Inc.

CBDY
Price unavailable
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
54 Visible periods
26 Metrics
Peer-ranked Benchmarks
Price Chart
59
Health
Fair
Neutral
auto_awesome

Analytical Summary

Target Group Inc. demonstrates solid fundamentals with strength in Return on Common Equity (%). However, watch Profit Margin (%) which shows concerning trends. Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap
Dividend Yield
Revenue Growth 10.8%
Op. Margin
ROIC
FCF / Share $-0.00
Trailing P/E
Price / Book
FCF Yield
Debt / Equity -0.85
info Valuation on last close.

54-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.38M
↑ +10.8%
Net Income Profit after all expenses
$-239.81K
↓ -9.1%
FCF / Share Free cash flow per share
$-0.00
↓ -138.0%
Long-Term Debt Long-term obligations
$7.33M
↓ -1.9%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
8
Returns
83
Financial Health
100
Cash Quality
45

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 13 years · 54 quarters